IQE International Quantum Epitaxy PLC

IQE plc: Holding(s) in Company

IQE plc: Holding(s) in Company

14 February 2020

IQE plc

(“IQE” or the “Company”)

Holding(s) in Company

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:IQE PLC
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)
Non-UK issuer 
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights 
An acquisition or disposal of financial instrumentsX
An event changing the breakdown of voting rights 
Other (please specify)iii: 
3. Details of person subject to the notification obligationiv
NameT. Rowe Price Associates, Inc.
City and country of registered office (if applicable)Baltimore, Maryland, USA
4. Full name of shareholder(s) (if different from 3.)v
NameT. Rowe Price International Ltd
City and country of registered office (if applicable)London, United Kingdom
5. Date on which the threshold was crossed or reachedvi:11 February 2020
6. Date on which issuer notified (DD/MM/YYYY):13 February 2020
7. Total positions of person(s) subject to the notification obligation
 % of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached14.06%3.53%17.59%796,159,802
Position of previous notification (if

applicable)
13.07%4.52%17.59% 





8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of

shares


ISIN code (if possible)
Number of voting rightsix% of voting rights
Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0009619924 111,940,501 14.06%
     
     
SUBTOTAL 8. A111,940,50114.06%
 



 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrumentExpiration

date
x
Exercise/

Conversion Period
xi
Number of voting rights that may be acquired if the instrument is

exercised/converted.
% of voting rights
Shares on loanN/ARight of recall on demand28,130,4703.53%
     
     
  SUBTOTAL 8. B 128,130,4703.53%
 



 
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrumentExpiration

date
x
Exercise/

Conversion Period
xi
Physical or cash

settlementxii
Number of voting rights % of voting rights
      
      
      
   SUBTOTAL 8.B.2  
 



 



 



9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii 
Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
X
Namexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
  T. Rowe Price Associates, Inc.7.83%0.45%8.28%
  T. Rowe Price International Ltd6.22%3.07%9.30%
    
    
    
 
10. In case of proxy voting, please identify:
Name of the proxy holder 
The number and % of voting rights held 
The date until which the voting rights will be held 
 
11. Additional informationxvi
 



Place of completionBaltimore, Maryland, USA
Date of completion13 February 2020

EN
14/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports by International Quantum Epitaxy PLC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch